1. Home
  2. MEI vs BCYC Comparison

MEI vs BCYC Comparison

Compare MEI & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methode Electronics Inc.

MEI

Methode Electronics Inc.

HOLD

Current Price

$11.27

Market Cap

338.7M

Sector

Technology

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.55

Market Cap

310.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEI
BCYC
Founded
1946
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
338.7M
310.7M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
MEI
BCYC
Price
$11.27
$4.55
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$9.00
$13.90
AVG Volume (30 Days)
1.2M
356.1K
Earning Date
03-05-2026
04-30-2026
Dividend Yield
2.61%
N/A
EPS Growth
49.14
N/A
EPS
N/A
N/A
Revenue
$908,300,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.24
N/A
52 Week Low
$4.88
$4.24
52 Week High
$15.55
$9.36

Technical Indicators

Market Signals
Indicator
MEI
BCYC
Relative Strength Index (RSI) 62.01 43.70
Support Level $6.67 $4.52
Resistance Level $15.55 $5.31
Average True Range (ATR) 1.28 0.20
MACD 0.02 -0.02
Stochastic Oscillator 34.77 31.25

Price Performance

Historical Comparison
MEI
BCYC

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: